Prague University of Economics and Business
Faculty of Finance and Accounting Study programme “Finance and Accounting”
Page 1/2
M a s t e r T h e s i s E v a l u a t i o n
Reviewer form
Student name: Asel Raimjanova
Title of the thesis: The Implementation of IFRS 16 by a Lessee
Year of the defence: 2021 Supervisor name
and affiliation:
David Procházka
Department of Financial Accounting and Auditing Reviewer name
and affiliation:
Libor Vašek
Department of Financial Accounting and Auditing
THESIS CONTENT SUMMARY:
The lease accounting applied by a lessee has been significantly changed effective 2019 due to IFRS 16. The thesis summarizes theoretical aspects of new provisions, including brief comparison with previous requirements (chapter 1 and 2), and provides analysis of IFRS 16 adoption made by real company (case study as an empirical part of the thesis) (chapter 3). For the case study student used data of pharmaceutical company Novartis AG.
OBJECTIONS AND REMARKS:
The theoretical part of the thesis provides comprehensive description of the new concept and related requirements contained in IFRS 16. To get better knowledges of a possible impact of IFRS 16, the thesis should have included a research whether there are other discussion papers or analyses written by another authors.
The empirical part of the thesis clearly displays process of IFRS 16 adoption in Novartis AG and related judgements made by Novartis AG. It would be quite helpful to provide also brief industry comparison whether other pharmaceutical companies have similar impact due to adoption of IFRS 16.
Page 2/2 QUESTIONS FOR THE DEFENCE:
1) What was the major challenge for Novartis AG while IFRS 16 was adopted?
2) Does the adoption of IFRS 16 by Novartis AG confirm an expectation that was formerly made for pharmaceutical industry?
3) Is the right of use concept contained in IFRS 16 a right approach to provide useful information to investors via financial statements?
